Gen-Probe Acquires GTI Diagnostics for $53 Million in Cash

Gen-Probe is pleased to announce the Company has acquired GTI Diagnostics, a privately held specialty diagnostics company focused on the transplantation, blood bank and specialty coagulation markets, for $53 million in cash.

News

• Important Announcement

A formulation change to the Stopping Solution has been identified for LIFECODES® ELISA-based assays. The new solution will eliminate hazards that are associated with the current reagent, as well as eliminate special chemical disposal needs.

Read More >